Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-25
1988-03-22
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514340, 514384, 544366, 546276, 548263, C07D24912, C07D40112, C07D40114, A61K 3141
Patent
active
047329009
ABSTRACT:
New 1,2,4-triazolo-carbamates of general formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the specification, are acetylcholinesterase inhibitors and may be used as drugs for the treatment of senile dementia.
REFERENCES:
patent: 4156085 (1979-05-01), Baldwin et al.
patent: 4160839 (1979-07-01), Kirkpatrick
patent: 4209515 (1980-06-01), Heckendorn et al.
patent: 4578479 (1986-03-01), Fukui et al.
patent: 4610717 (1986-09-01), Mansuri et al.
Sunderdiek et al., CA 81:91438k (1974).
Hoyer et al., CA 87:68245k (1977).
Ensinger Helmut
Frolke Wilhelm
Harreus Albrecht
Hinzen Dieter
Kuhn Franz-Josef
Boehringer Ingelheim KG
Dinner D. L.
Frankhouser David E.
Hollrah Glennon H.
Stempel Alan R.
LandOfFree
1,2,4-triazolo-carbamates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,4-triazolo-carbamates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,4-triazolo-carbamates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442266